Literature DB >> 25114404

Hairy cell leukemia: clinicopathological and immunophenotypic study.

Kaumudi Konkay1, Megha S Uppin1, Shantveer G Uppin1, D Raghunadha Rao2, Ch Geetha1, T Roshni Paul1.   

Abstract

Hairy cell leukemia (HCL) is a rare neoplasm of mature small B lymphoid cells with characteristic circumferential 'hairy projections' involving the peripheral blood, bone marrow and splenic red pulp. With the advent of immunophenotyping and newer treatment modalities, prolonged remission can be achieved after a definitive diagnosis. Due to the rarity of this condition and presence of only a few case series from India, this work was undertaken. The aim was to study the clinico-pathologic and immunophenotypic features of all cases diagnosed as hairy cell leukemia. The cases were retrieved from Hematopathology records, between 1991 and 2012. The complete clinical details, investigations, treatment and follow-up were obtained from Medical Oncology records. The peripheral blood picture, bone marrow cytology and trephine sections along with special stains were reviewed. There were 12 cases of HCL during the study period with a M:F ratio of 11:1. Of these, ten were diagnosed as classical HCL and two as variant HCL. The most common clinical manifestations were fever, easy fatigability and weakness. Splenomegaly was present in 81.8 % cases. Though all the patients showed some form of cytopenia, there were three (25 %) patients with leucocytosis. The smears from all patients showed atypical lymphoid cells with circumferential hairy projections. TRAP was positive in 9 patients (81.8 %). Immunophenotyping was done in six cases, four were confirmed as HCL and two were diagnosed as HCL-v. The patients treated with Cladribine generally had a good response. The characteristic morphology of the hairy cells; along with correlation with the clinical features, TRAP positivity and immunophenotyping by flow cytometry is essential for diagnosis. Treatment response with Cladribine is good and has prolonged remission rates.

Entities:  

Keywords:  Cytopenia; Hairy cells; Immunophenotyping; Splenomegaly

Year:  2013        PMID: 25114404      PMCID: PMC4115087          DOI: 10.1007/s12288-013-0231-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

1.  Hairy cell leukemia with marked lymphocytosis.

Authors:  Brian Patrick Adley; Xiaoping Sun; John M Shaw; Daina Variakojis
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

2.  Leukemic reticuloendotheliosis.

Authors:  B A BOURONCLE; B K WISEMAN; C A DOAN
Journal:  Blood       Date:  1958-07       Impact factor: 22.113

3.  Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience.

Authors:  L T Yam; A J Janckila; C Y Li; W K Lam
Journal:  Leukemia       Date:  1987-04       Impact factor: 11.528

4.  Is male predominance (4/1) in hairy cell leukaemia related to occupational exposure to ionizing radiation, benzene and other solvents?

Authors:  G Flandrin; S Collado
Journal:  Br J Haematol       Date:  1987-09       Impact factor: 6.998

5.  Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases.

Authors:  M Blasińska-Morawiec; T Robak; E Krykowski; A Hellmann; H Urbańska-Ryś
Journal:  Leuk Lymphoma       Date:  1997-04

6.  Atypical hairy cell leukemia.

Authors:  M L Wu; H C Kwaan; C L Goolsby
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

Review 7.  Hairy cell leukemia: an update.

Authors:  Grant R Goodman; Kelly J Bethel; Alan Saven
Journal:  Curr Opin Hematol       Date:  2003-07       Impact factor: 3.284

8.  Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital.

Authors:  Komal S Galani; P G Subramanian; Vijaya S Gadage; Khaliqur Rahman; M S Ashok Kumar; Shaila Shinde; Shashikant Mahadik; Rashida Ansari; Manju Sengar; Hari Menon; Reena Nair; Sumeet Gujral
Journal:  Indian J Pathol Microbiol       Date:  2012 Jan-Mar       Impact factor: 0.740

9.  Hairy cell leukemia: clinical, pathological and ultrastructural findings in Asian-Indians.

Authors:  T Chatterjee; I Panigrahi; M Mahapatra; H P Pati; R Kumar; R Naithani; S Wadhwa; V P Choudhry; R Saxena
Journal:  Indian J Cancer       Date:  2008 Apr-Jun       Impact factor: 1.224

10.  2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.

Authors:  T Robak; M Błasińska-Morawiec; J Błoński; A Hellmann; K Hałaburda; L Konopka; S Kotlarek-Haus; S Potoczek; J Hansz; A Dmoszyńska; I Urasiński; B Zdziarska; J Dwilewicz-Trojaczek; J Hołowiecki; A B Skotnicki
Journal:  Eur J Haematol       Date:  1999-01       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.